Increased Resistance to Tumor Graft in Mice Infected by Vaccinal Strains of Brucella Abortus
- 1 January 1980
- book chapter
- Published by Springer Nature
- Vol. 75, 92-99
- https://doi.org/10.1007/978-3-642-81491-4_15
Abstract
Kinetics of proliferation in vivo and the effect on murine tumors of the vaccinal strain Brucella abortus B19 and two derivatives, 19BA and B19R, were studied. Inocula of 5 × 106 organisms of each strain produced comparable infections peaking on day 8. Several protocols of Brucella treatment yielded favorable results in EL4 lymphoma and Lewis tumor. The treatment for EL4 lymphoma seemed optimal 8–14 days after infection with 5 × 106 — 5 × 107 organisms. In comparison with BCG, Brucella grew faster in vivo and accumulated more in the spleen. The effects of BCG and Brucella were comparable on EL4 lymphoma, but BCG was less effective than Brucella on Lewis tumor. The results encourage trials using live Brucella vaccine as an antitumor agent in man.Keywords
This publication has 6 references indexed in Scilit:
- Resistance to transplanted cancer in mice increased by live Brucella vaccineBritish Journal of Cancer, 1978
- Influence of the antigenicity of Brucella preparations on modulation of the immune response to sheep erythrocytesInfection and Immunity, 1978
- Effect of Brucella abortus Infection (Vaccine Strain 19BA) on Rauscher Leukemia Virus and LI210 Leukemia in MiceJNCI Journal of the National Cancer Institute, 1974
- Resistance to Murine Tumors Conferred by Chronic Infection with Intracellular Protozoa, Toxoplasma gondii and Besnoitia jellisoniThe Journal of Infectious Diseases, 1971
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969